Morgan Stanley
SRTA

Morgan Stanley’s Strata Critical Medical Inc SRTA Stock Holding History

Morgan Stanley’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Sell
425,398
-72,460
-15% -$381K ﹤0.01% 4790
2026
Q1 		$2.08M Sell
497,858
-268,591
-35% -$1.29M ﹤0.01% 4743
2025
Q4 		$3.69M Sell
766,449
-24,716
-3% -$120K ﹤0.01% 4407
2025
Q3 		$4M Sell
791,165
-141,241
-15% -$624K ﹤0.01% 4325
2025
Q2 		$3.76M Buy
932,406
+61,691
+7% +$201K ﹤0.01% 4290
2025
Q1 		$2.38M Buy
870,715
+189,712
+28% +$681K ﹤0.01% 4492
2024
Q4 		$2.89M Buy
681,003
+289,970
+74% +$1.1M ﹤0.01% 4430
2024
Q3 		$1.15M Buy
391,033
+77,436
+25% +$246K ﹤0.01% 4974
2024
Q2 		$1.09M Sell
313,597
-13,123
-4% -$43.8K ﹤0.01% 4905
2024
Q1 		$931K Sell
326,720
-607,869
-65% -$1.88M ﹤0.01% 4985
2023
Q4 		$3.3M Buy
934,589
+256,391
+38% +$736K ﹤0.01% 4212
2023
Q3 		$1.76M Buy
678,198
+505,888
+294% +$1.78M ﹤0.01% 4470
2023
Q2 		$679K Buy
172,310
+63,344
+58% +$201K ﹤0.01% 5055
2023
Q1 		$368K Buy
108,966
+35,414
+48% +$144K ﹤0.01% 5429
2022
Q4 		$263K Buy
73,552
+13,785
+23% +$58.9K ﹤0.01% 5555
2022
Q3 		$239K Sell
59,767
-1,330
-2% -$6.83K ﹤0.01% 5645
2022
Q2 		$273K Sell
61,097
-3,205
-5% -$23.1K ﹤0.01% 5735
2022
Q1 		$546K Buy
64,302
+3,375
+6% +$23.7K ﹤0.01% 5352
2021
Q4 		$538K Sell
60,927
-9,937
-14% -$94.4K ﹤0.01% 5497
2021
Q3 		$737K Sell
70,864
-24,686
-26% -$216K ﹤0.01% 5260
2021
Q2 		$1M Buy
95,550
+9,892
+12% +$97.6K ﹤0.01% 5077
2021
Q1 		$881K Sell
85,658
-40,809
-32% -$568K ﹤0.01% 4813
2020
Q4 		$1.4M Buy
126,467
+126,293
+72,582% +$1.29M ﹤0.01% 4445
2020
Q3 		$2K Sell
174
-236
-58% -$2.38K ﹤0.01% 6557
2020
Q2 		$4K Sell
410
-138
-25% -$1.35K ﹤0.01% 6329
2020
Q1 		$5K Sell
548
-645
-54% -$6.4K ﹤0.01% 6191
2019
Q4 		$12K Buy
+1,193
New +$11.7K ﹤0.01% 6215

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley's SRTA Position: Q2 2026 in Review

Morgan Stanley reduced its Strata Critical Medical Inc (SRTA) stake by 15% in Q2 2026, selling an estimated $381K and leaving 425,398 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4790.

Morgan Stanley first reported a position in SRTA in Q4 2019 and has held it in 27 quarters since. The position peaked at $4M in Q3 2025. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Morgan Stanley held 425,398 shares of Strata Critical Medical Inc worth $2.24M as of Q2 2026.
  • Morgan Stanley sold 72,460 Strata Critical Medical Inc shares in Q2 2026, an estimated $381K.
  • Strata Critical Medical Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4790 holding.
  • Morgan Stanley first reported a position in Strata Critical Medical Inc in Q4 2019 and has held it in 27 quarters since.
  • Morgan Stanley's Strata Critical Medical Inc position peaked at $4M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.